Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.539
EU - Europa 2.850
AS - Asia 1.523
SA - Sud America 91
OC - Oceania 67
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.117
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.437
IT - Italia 840
GB - Regno Unito 660
SG - Singapore 477
SE - Svezia 412
CN - Cina 367
DE - Germania 211
HK - Hong Kong 178
FI - Finlandia 124
FR - Francia 107
TR - Turchia 101
JP - Giappone 97
ID - Indonesia 95
UA - Ucraina 95
RU - Federazione Russa 94
BG - Bulgaria 69
IE - Irlanda 62
AU - Australia 59
CA - Canada 59
IN - India 51
BR - Brasile 37
LT - Lituania 35
PK - Pakistan 33
NL - Olanda 32
MX - Messico 30
VN - Vietnam 30
TN - Tunisia 28
KR - Corea 23
MY - Malesia 21
AR - Argentina 19
PL - Polonia 18
CL - Cile 13
PT - Portogallo 13
BE - Belgio 12
BZ - Belize 12
HU - Ungheria 12
PE - Perù 12
ES - Italia 11
IR - Iran 10
NZ - Nuova Zelanda 8
PH - Filippine 8
CO - Colombia 7
EG - Egitto 7
RO - Romania 7
CH - Svizzera 6
RS - Serbia 6
AT - Austria 5
JO - Giordania 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
LU - Lussemburgo 4
SA - Arabia Saudita 4
BD - Bangladesh 3
EC - Ecuador 3
NP - Nepal 3
DZ - Algeria 2
GR - Grecia 2
IQ - Iraq 2
KE - Kenya 2
KH - Cambogia 2
LV - Lettonia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
CY - Cipro 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
MA - Marocco 1
MM - Myanmar 1
NO - Norvegia 1
Totale 11.117
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.210
Fairfield 853
Chandler 507
Ashburn 478
Southend 451
Singapore 386
Woodbridge 341
Houston 281
Seattle 267
Nyköping 264
Wilmington 259
Cambridge 240
Ann Arbor 215
Hong Kong 165
Jacksonville 142
Modena 112
Dearborn 110
Helsinki 104
San Diego 95
Jakarta 92
New York 89
Beijing 72
Sofia 69
Princeton 68
Redwood City 64
Milan 62
London 52
Perth 46
Moscow 44
Shanghai 41
Bremen 39
Eugene 36
Izmir 36
Dublin 34
Rome 31
Bologna 27
Los Angeles 26
Chicago 25
Falls Church 25
San Jose 25
Munich 24
Tokyo 23
Bari 21
Dong Ket 18
Boardman 17
Catania 14
Toronto 14
Frankfurt am Main 13
Manchester 13
Ottawa 13
Reggio Nell'emilia 13
Belize City 12
Santiago 12
Brussels 11
Mumbai 11
Norwalk 11
Buffalo 10
Guangzhou 10
Menlo Park 10
Parma 10
Amsterdam 9
Gangnam-gu 9
Hamilton 9
Hounslow 9
Las Vegas 9
São Paulo 9
Bolu 8
Cagliari 8
Hangzhou 8
Kilburn 8
Louisville 8
Debrecen 7
Kolkata 7
Monza 7
Paris 7
Phoenix 7
San Francisco 7
Sassari 7
Wuhan 7
Ahmedabad 6
Atlanta 6
Bogotá 6
Casarano 6
Chiclayo 6
Chiswick 6
Columbus 6
Dallas 6
Florence 6
Gloucester 6
Ho Chi Minh City 6
Istanbul 6
Lyon 6
Mexico City 6
Nagoya 6
Tsu 6
Ankara 5
Buenos Aires 5
Caserta 5
Chennai 5
Cremona 5
Totale 8.034
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 986
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 289
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 274
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 242
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 232
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 228
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 228
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 224
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 223
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 213
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 205
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 195
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 191
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 190
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 179
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 176
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 174
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 168
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 167
Severe alopecia complicating systemic sclerosis 165
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 161
Nailfold videocapillaroscopy in antisynthetase syndrome 160
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 160
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 159
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 159
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 157
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 156
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 153
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 150
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 148
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 147
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 144
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 141
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 139
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 138
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 136
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 133
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 128
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 124
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 122
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 119
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 107
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 104
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 103
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 103
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 101
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 100
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 99
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 96
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 92
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 91
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 90
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 88
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 86
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 85
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 84
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 84
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 84
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 79
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 78
Fibrosing interstitial lung disease in primary Sjogren syndrome 77
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 76
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 69
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 66
Rheumatoid arthritis related interstitial lung disease 65
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 65
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 63
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 62
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 61
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 60
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 58
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 50
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 45
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 44
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 43
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 41
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 39
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 39
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 38
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 37
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 36
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 35
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 33
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 31
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 31
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 29
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 28
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 27
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 26
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 25
Granuloma annulare as a possible new adverse effect of topiramate 25
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 23
Trattamento con Tocilizumab in monoterapia dopo trattamento con glucocorticoidi per breve periodo in pazienti con arterite a cellule giganti con coinvolgimento dei grandi vasi: effetti sui checkpoint immunitari solubili 22
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 21
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 21
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 20
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 20
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 19
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 18
Personalized Medicine and Machine Learning: A Roadmap for the Future 18
Totale 11.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020869 0 0 0 0 0 180 183 140 154 91 68 53
2020/20211.900 133 65 134 138 196 135 225 197 184 211 143 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20252.310 143 69 108 319 961 710 0 0 0 0 0 0
Totale 11.345